Novavax, Inc. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/248608ab-8b49-431b-8513-a905f1959e4d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $452.8M | 2025-01-01 – 2025-12-31 | evidence 0001000694-26-000007 |
| FY 2024 | $-248.9M | 2024-01-01 – 2024-12-31 | evidence 0001000694-25-000004 |
| FY 2023 | $-566.5M | 2023-01-01 – 2023-12-31 | evidence 0001000694-24-000007 |
| FY 2022 | $-644.7M | 2022-01-01 – 2022-12-31 | evidence 0001000694-23-000005 |
| FY 2021 | $-1.7B | 2021-01-01 – 2021-12-31 | evidence 0001000694-22-000004 |
| FY 2020 | $-416.7M | 2020-01-01 – 2020-12-31 | evidence 0001000694-21-000004 |
| FY 2019 | $-120.6M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-031944 |
| FY 2018 | $-173.9M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014640 |
| FY 2017 | $-171.7M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-014686 |
| FY 2016 | $-269.1M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-011334 |
| FY 2015 | $-157.2M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-084770 |
| FY 2014 | $-83.7M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-012379 |
| FY 2013 | $-52.4M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-014965 |
| FY 2012 | $-29.7M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-014545 |
| FY 2011 | $-21.6M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-014910 |
| FY 2010 | $-38.5M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-014910 |
| FY 2009 | $-37.4M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-014910 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).